CryoPort, Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by CryoPort, Inc. on January 6, 2006, regarding corporate governance changes and listing applications occurring in December 2005.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and regulatory status.
Material Changes
- Board Expansion: On December 15, 2005, the Board of Directors expanded from five to seven members.
- New Appointments: Two independent directors were appointed: Thomas S. Fischer, PhD, and Stephen L. Scott.
- Strategic Rationale: The expansion was executed to ensure compliance with the Sarbanes-Oxley Act and to meet listing requirements for the NASDAQ Capital Markets Exchange.
- Listing Application: On December 16, 2005, the Company filed an application to list on the NASDAQ Capital Markets Exchange.
Outlook and Management Commentary
Management expects approval for listing on the NASDAQ Capital Markets Exchange once the SEC completes its comment process on the Company's Form 10-SB filing. The new directors bring significant experience in healthcare operations, information technology, and corporate growth planning.
Investor Verification Checklist
- Confirm the status of the SEC comment process on the Form 10-SB filing.
- Verify the official listing approval date on the NASDAQ Capital Markets Exchange.
- Review the Form 10-SB for detailed financial data not included in this 8-K.
- Assess the impact of the new board composition on future strategic direction.